4//SEC Filing
Onopchenko John 4
Accession 0001013606-19-000172
CIK 0001013606other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:31 PM ET
Size
10.5 KB
Accession
0001013606-19-000172
Insider Transaction Report
Form 4
Onopchenko John
Chief Operating Officer
Transactions
- Disposition to Issuer
Option to Purchase
2019-09-27−19,864→ 0 totalExercise: $43.60From: 2019-05-02Exp: 2028-05-02→ Common Stock (19,864 underlying) - Award
Option to Purchase
2019-09-27+12,968→ 12,968 totalExercise: $4.71From: 2020-09-10Exp: 2026-09-10→ Common Stock (12,968 underlying) - Disposition to Issuer
Option to Purchase
2019-09-27−19,034→ 0 totalExercise: $53.00From: 2018-10-30Exp: 2027-10-30→ Common Stock (19,034 underlying)
Footnotes (4)
- [F1]Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter.
- [F2]The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 19,034 shares of common stock granted to the reporting person on October 30, 2017, and (ii) an option for 19,864 shares of common stock granted to the reporting person on May 2, 2018. In exchange, the reporting person received a new stock option, for 12,968 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019.
- [F3]One-third of the options vested on May 2, 2019 and the remaining balance was scheduled to vest in equal annual installments thereafter.
- [F4]The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001403100
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:31 PM ET
- Size
- 10.5 KB